The use of intravenous immunoglobulin gamma for the treatment of severe coronavirus disease 2019: a randomized placebo-controlled double-blind clinical trial

The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus

(2020) Calvin J Gordon et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

(2020) Chaolin Huang et al.   LANCET

A Novel Coronavirus from Patients with Pneumonia in China, 2019

(2020) Na Zhu et al.   NEW ENGLAND JOURNAL OF MEDICINE

Lactate dehydrogenase levels predict coronavirus disease 2019 (COVID-19) severity and mortality: A pooled analysis

(2020) Brandon Michael Henry et al.   AMERICAN JOURNAL OF EMERGENCY MEDICINE

Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study

(2020) Rong-Hui Du et al.   EUROPEAN RESPIRATORY JOURNAL

Effect of regular intravenous immunoglobulin therapy on prognosis of severe pneumonia in patients with COVID-19

(2020) Yun Xie et al.   JOURNAL OF INFECTION

COVID‐19 patients' clinical characteristics, discharge rate, and fatality rate of meta‐analysis

(2020) Long‐quan Li et al.   JOURNAL OF MEDICAL VIROLOGY

Real estimates of mortality following COVID-19 infection

(2020) David Baud et al.   LANCET INFECTIOUS DISEASES

Early dynamics of transmission and control of COVID-19: a mathematical modelling study

(2020) Adam J Kucharski et al.   LANCET INFECTIOUS DISEASES

The COVID-19 vaccine development landscape

(2020) Tung Thanh Le et al.   NATURE REVIEWS DRUG DISCOVERY

Remdesivir for the Treatment of Covid-19 — Preliminary Report

(2020) John H. Beigel et al.   NEW ENGLAND JOURNAL OF MEDICINE

A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19

(2020) Bin Cao et al.   NEW ENGLAND JOURNAL OF MEDICINE

Update on use of chloroquine/hydroxychloroquine to treat coronavirus disease 2019 (COVID-19)

(2020) Jianjun Gao et al.   BioScience Trends

High-Dose Intravenous Immunoglobulin as a Therapeutic Option for Deteriorating Patients With Coronavirus Disease 2019

(2020) Wei Cao et al.   Open Forum Infectious Diseases

Characteristics and Mortality of Hospitalized Patients With COVID-19 in Iran: A National Retrospective Cohort Study

(2020) Mohammad Jalili et al.   ANNALS OF INTERNAL MEDICINE

Epidemiological characteristics of coronavirus disease 2019 (COVID-19) patients in IRAN: A single center study

(2020) Mohamad Nikpouraghdam et al.   JOURNAL OF CLINICAL VIROLOGY

Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial

(2019) Richard T Davey et al.   Lancet Respiratory Medicine

IVIG-mediated effector functions in autoimmune and inflammatory diseases

(2017) Caroline Galeotti et al.   INTERNATIONAL IMMUNOLOGY

Clinical Course and Outcomes of Critically Ill Patients With Middle East Respiratory Syndrome Coronavirus Infection

(2014) Yaseen M. Arabi et al.   ANNALS OF INTERNAL MEDICINE

Respiratory Syncytial Virus Infection in Patients with Hematological Diseases: Single-Center Study and Review of the Literature

(2007) N. Khanna et al.   CLINICAL INFECTIOUS DISEASES